Summary and Look to the Future
Autoimmune pancreatitis (AIP) is a rare immunological disorder that requires a high degree of expertise from gastroenterologists, pathologists, and radiologists – as provided in this book. The diagnosis has traditionally been based on pancreatic imaging, principally ERCP and CT scans, but recent advances in endoscopic ultrasound (EUS) and MRI have provided improved accuracy. Biopsies of the pancreas, guided by EUS, have made it possible to provide a tissue diagnosis. In addition, ampullary and duodenal biopsies can provide tissue evidence of IgG4 plasma cell infiltration of the upper gastrointestinal tract. While international consensus definitions allow to distinguish between type 1 AIP (lymphoplasmacytic sclerosing pancreatitis) and type 2 AIP (idiopathic duct-centric pancreatitis), their underlying pathophysiology remains largely obscure. Future research will aim at a refinement of diagnostic tests, specifically for type 2 AIP where IgG4 is not elevated and for monitoring therapy. It will also have to identify parameters for recurrence, define the appropriate treatment intervals for long-term immunosuppression, and establish alternatives to corticosteroid treatment. We hope that enthusiasm to invest in clinical research on AIP shall not fade and patients with other varieties of pancreatitis may benefit from its progress as well.
KeywordsEurope Corticosteroid Pancreatitis Trypsin Cyclosporine
Some of the points discussed here have recently been reviewed in a commentary in the journal Gut (2011 May;60(5):565–6). The authors thank Julia Mayerle for helpful discussions.
- 11.Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las HG, Corts J, Navarro S, Mora J, Lopez-Hoyos M, Sabater L, Ferrandez A, Bautista D, Perez-Mateo M, Mery S, Sastre J. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut. 2005;54:703–9.PubMedCrossRefGoogle Scholar
- 12.Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T; Autoimmune Pancreatitis International Cooperative Study Group (APICS). Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;39:549–54.Google Scholar
- 16.Sugumar A, Levy MJ, Kamisawa T, Webster GJM, Kim MH, Enders F, Amin Z, Baron TH, Chapman MH, Church NI, Clain JE, Egawa N, Johnson GJ, Okazaki K, Pearson RK, Pereira SP, Petersen BT, Read S, Sah RP, Sandanayake NS, Takahashi N, Topazian MD, Uchida K, Vege SS, Chari ST. Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicenter study. Gut. 2011;60:666–70.PubMedCrossRefGoogle Scholar
- 19.Löhr JM, Faissner R, Koczan D, Bewerunge P, Bassi C, Brors B, Eils R, Frulloni L, Funk A, Halangk W, Jesnowski R, Kaderali L, Kleeff J, Krüger B, Lerch MM, Lösel R, Magnani M, Neumaier M, Nittka S, Sahin-Tóth M, Sänger J, Serafini S, Schnölzer M, Thierse HJ, Wandschneider S, Zamboni G, Klöppel G. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol. 2010;105:2060–71.PubMedCrossRefGoogle Scholar
- 20.Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M. Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471–7.Google Scholar